Local company to roll out new premature ejaculation drug

Published: 2011-04-01 06:57:00
Updated: 2011-04-01 06:57:00
Jinyang Pharmaceutical and CTC Bio have recently announced that they will carry out Phase 3 clinical trials for the development of premature ejaculation (PE) drug.

The results of Phase 2 study demonstrated the safety and efficacy of the PE drug in 100 PE patients, officials said.

They added...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.